PD Dr. med. Markus Loibl is a spine surgeon at Schulthess Clinic, Zurich, Switzerland. During his post-doc he investigated the use of endothelial progenitor cells to improve neovascularization in cell-based tissue regeneration in vitro and in vivo in small and large animal models. Later projects during residency focus on the interactions between autologous growth factors and mesenchymal stem cells from bone marrow and adipose tissue in order to improve engraftment after stem cell transplantation. As a surgeon with a strong basic science background, he is interested in translating basic science knowledge to clinical application, with the aim to restore spinal function. He would like to address future cell-based treatment options in the field of regenerative medicine on an interdisciplinary scientific platform.
His research resulted in more than 40 peer-reviewed publications. Dr. Loibl has on-going collaborations in Germany (Regensburg: Prof. Nerlich, Prof. Prantl), Switzerland (Davos: Prof. Alini), and Austria (Graz: Prof. Grechenig).